SciClone Pharmaceuticals, Inc.
901 Mariner's Island Boulevard
Suite 205
San Mateo
California
94404
United States
Tel: 650-358-3456
Fax: 650-358-3469
270 articles with SciClone Pharmaceuticals, Inc.
-
SciClone Pharmaceuticals, Inc.'s ZADAXIN Granted Orphan Drug Designation For Malignant Melanoma In United States
3/20/2006
-
SciClone Pharmaceuticals, Inc. Reports Results For Fourth Quarter And Year-End 2005
3/1/2006
-
SciClone Pharmaceuticals, Inc. To Report Fourth Quarter And Year-End 2005 Results On March 1, 2006
2/8/2006
-
SciClone Pharmaceuticals, Inc. Reports Results From ZADAXIN Proof-Of-Concept Liver Cancer Trial
12/21/2005
-
SciClone Pharmaceuticals, Inc. Says Hepatitis C Drug Fails To Meet Target In Trials; Shares Plunge
12/14/2005
-
SciClone Pharmaceuticals, Inc. And Sigma-Tau Pharmaceuticals Report Promising Interim Phase 2 Results In Advanced-Stage Malignant Melanoma Trial
12/14/2005
-
SciClone Pharmaceuticals, Inc. Announces Data Presentations At AASLD Regarding ZADAXIN's Activity In Hepatitis B
11/16/2005
-
SciClone Pharmaceuticals, Inc. Announces Data Presentations At AASLD Regarding ZADAXIN's Activity In Hepatitis B
11/16/2005
-
The Day In Review: Biotech Consolidates Again
8/8/2005
-
The Day In Review: Biotech Takes Another Loss
6/7/2005